We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > blood disorder

News List

Sutimlimab shows promise for hard-to-treat, rare blood disorder worldpharmanews
December 19, 2018
In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin disease, a rare chronic blood disorder for which there are currently no approved treatments.
Sangamo, Pfizer Announce First Patient Receives SB-525 Treatment in Clinical Trial expressbpd
August 28, 2017
Sangamo Therapeutics and Pfizer announced the first patient received treatment in the Phase 1/2 clinical trial (Alta trial) evaluating SB-525, an investigational gene therapy for patients with Hemophilia A, a rare genetic blood disorder.
First patient cured of rare blood disorder worldpharmanews
March 22, 2017
Using a technique that avoids the use of high-dose chemotherapy and radiation in preparation for a stem cell transplant...